Table 3 Associations between changes in plasma levels of PFAS and changes in fasting glucose levels during 10 years of follow-up.

	Adjusted			Adjusted also for BMI			Sex interaction			Women only			Men only
	β	95% CI	p-value	β	95% CI	p-value	β	95% CI	p-value	β	95% CI	p-value	β	95% CI	p-value
PFOS	−0.003	−0.014, 0.009	0.60	−0.003	−0.01, 0.009	0.62	−0.004	−0.01, 0.004	0.28	−0.02	−0.04, −0.002	0.05	0.007	−0.009, 0.02	0.39
PFOA	−0.02	−0.04, −0.004	0.04	−0.02	−0.04, −0.004	0.046	−0.01	−0.02, −0.002	0.02	−0.03	−0.05, −0.01	0.02	−0.007	−0.03, 0.01	0.49
PFHxS	−0.008	−0.02, 0.004	0.22	−0.006	−0.02, 0.006	0.34	−0.006	−0.01, 0.002	0.12	−0.01	−0.03, 0.006	0.17	0.001	−0.02, 0.02	0.97
PFNA	−0.009	−0.02, 0.007	0.25	−0.009	−0.02, 0.005	0.23	−0.008	−0.02, 0.002	0.11	−0.02	−0.04, −0.0004	0.12	−0.005	−0.02, 0.01	0.66
PFDA	−0.01	−0.03, 0.006	0.12	−0.01	−0.03, 0.006	0.17	−0.008	−0.02, 0.002	0.11	−0.02	−0.04, −0.0004	0.14	−0.008	−0.03, 0.01	0.48
PFUnDA	−0.02	−0.04, −0.004	0.02	−0.02	−0.04, 0.004	0.047	−0.01	−0.02, −0.0002	0.02	−0.03	−0.05, −0.01	0.03	−0.008	−0.03, 0.02	0.52

The fully adjusted model was adjusted for sex, participation time, BMI, insulin and diabetes medication, smoking, physical exercise and glomerular filtration rate (age was the same in all individuals). Significant p- values and associated results are marked in bold.
β beta (regression coefficient), PFHxS perfluorohexane sulfonic acid, PFOS perfluorooctanesulfonic acid, PFOA perfluorooctanoic acid, PFNA perfluorononanoic acid, PFDA perfluorodecanoic acid, PFUnDA perfluoroundecanoic acid, SE standard error.

Quick links

Search